The effect of mephentermine sulfate on myocardial oxygen consumption, myocardial efficiency and peripheral vascular resistance.
暂无分享,去创建一个
[1] E. Braunwald,et al. Determinants of Duration and Mean Rate of Ventricular Ejection , 1958, Circulation research.
[2] E. Braunwald,et al. Performance characteristics and oxygen debt in a nonfailing, metabolically supported, isolated heart preparation. , 1957, The American journal of physiology.
[3] E. Braunwald,et al. Hemodynamic determinants of coronary flow: effect of changes in aortic pressure and cardiac output on the relationship between myocardial oxygen consumption and coronary flow. , 1957, The American journal of physiology.
[4] E. Braunwald,et al. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. , 1957, The American journal of physiology.
[5] A C BURTON,et al. The importance of the shape and size of the heart. , 1957, American heart journal.
[6] E. Braunwald,et al. Alterations in Central Blood Volume and Cardiac Output Induced by Positive Pressure Breathing and Counteracted by Metaraminol (Aramine) , 1957, Circulation research.
[7] D. Sabiston,et al. Use and Application of the Cuvette Densitometer as an Oximeter , 1957, Circulation research.
[8] S. Sarnoff,et al. Effect of Aramine‐Induced Smooth Muscle Contraction on Length‐Tension Diagrams of Venous Strips , 1957, Circulation research.
[9] P. Lynch,et al. Changes in properties of heart muscle due to mephentermine. , 1956, The American journal of physiology.
[10] R. Rushmer. CARDIAC DIAGNOSIS: A PHYSIOLOGIC APPROACH , 1956 .
[11] V. Collins,et al. USE OF MEPHENTERMINE AS A PRESSOR AGENT DURING SPINAL ANESTHESIA , 1955, Anesthesiology.
[12] Davis Hs,et al. A clinical evaluation of mephentermine as a vasopressor in surgery and obstetrics. , 1955 .
[13] P. Lynch,et al. MEPHENTERMINE AS AN ANTIFIBRILLATORY DRUG AGAINST CYCLOPROPANE-EPINEPHRINE VENTRICULAR FIBRILLATION , 1955, Anesthesiology.
[14] J. Seifter,et al. The effect of mephentermine on hypodynamic and arrhythmic isolated frog hearts. , 1954, Journal of Pharmacology and Experimental Therapeutics.
[15] S. Sarnoff,et al. Ventricular Function: V. The Circulatory Effects of Aramine; Mechanism of Action of "Vasopressor" Drugs in Cardiogenic Shock , 1954, Circulation.
[16] E BERGLUND,et al. Ventricular Function: I. Starling's Law of the Heart Studied by Means of Simultaneous Right and Left Ventricular Function Curves in the Dog , 1954, Circulation.
[17] T. Ferguson,et al. An Improved Cuvette Densitometer for Cardiac Output Determination by the Dye‐Dilution Method , 1953 .
[18] S. Sarnoff,et al. The Potter Electroturbinometer: An Instrument for Recording Total Systemic Blood Flow in the Dog , 1953, Circulation research.
[19] M. Cotten,et al. Comparative heart contractile force effects of equipressor doses of several sympathomimetic amines. , 1953, The Journal of pharmacology and experimental therapeutics.
[20] H. Hellerstein,et al. Shock accompanying myocardial infarction: treatment with pressor amines amines. , 1952, American heart journal.
[21] H. Hellerstein,et al. Mephentermine: an effective pressor amine; clinical and laboratory observations. , 1952, American heart journal.
[22] R. E. Shipley,et al. An Improved Recording Rotameter , 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[23] Hellerstein Hk,et al. The treatment of the hypotensive state accompanying myocardial infarction. , 1951 .
[24] R. W. Eckstein,et al. Effects of control of cardiac work upon coronary flow and O2 consumption after sympathetic nerve stimulation. , 1950, The American journal of physiology.
[25] L. Goodman,et al. THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .
[26] R H Woods,et al. A Few Applications of a Physical Theorem to Membranes in the Human Body in a State of Tension. , 1892, Journal of anatomy and physiology.